DNA X, Inc. (SONM)

NASDAQ:
SONM
| Latest update: Apr 15, 2026, 5:37 PM

Stock events for DNA X, Inc. (SONM)

The past six months have been marked by significant corporate actions. On January 27, 2026, Sonim Technologies rebranded as DNA X, Inc. On January 26, 2026, NEXA completed the acquisition of Sonim's operating assets. On December 31, 2025, stockholders approved the asset sale to NEXA. On November 25, 2025, Sonim Technologies filed a preliminary proxy statement. On October 31, 2025, Sonim Technologies reported its Third Quarter 2025 financial results. The company's stock has experienced considerable volatility, with a 52-week trading range between $2.52 and $38.52 as of April 2026.

Demand Seasonality affecting DNA X, Inc.’s stock price

Information explicitly detailing the demand seasonality for DNA X, Inc.'s current digital asset management products and services is not available. For its former rugged mobile solutions business, there is no explicit information on demand seasonality, although the target markets might suggest some cyclicality based on project cycles or government budgets.

Overview of DNA X, Inc.’s business

DNA X, Inc., formerly Sonim Technologies, has transitioned from providing rugged mobile solutions to focusing on digital asset management. The company rebranded in January 2026 after selling its rugged mobile assets to NEXA. Historically, Sonim Technologies operated in the Technology sector, offering ruggedized cell phones and connected solutions for task workers in demanding environments. Now, DNA X, Inc. is developing the DNA X platform for automated decentralized exchange trading strategies and is categorized under the "Software - Infrastructure" industry.

SONM’s Geographic footprint

Historically, as Sonim Technologies, DNA X, Inc. provided enterprise 5G solutions across the United States, Canada, Europe, the Middle East, and the Asia Pacific region, distributing products through wireless carriers and distributors. With its new focus on digital asset management, the company is positioned to capitalize on the global expansion of digital assets.

SONM Corporate Image Assessment

Historically, as Sonim Technologies, the company had a strong reputation as a provider of ruggedized cell phones. Following the strategic pivot to digital asset management, specific information detailing the brand reputation of the new DNA X, Inc. is not readily available. An analysis by TipRanks' AI Analyst Spark in January 2026 rated SONM as "Neutral," noting concerns about weak financial performance and the sustainability of the business model.

Ownership

As of April 7, 2026, DNA X, Inc. has 15 institutional owners and shareholders holding a total of 84,537 shares, with Potomac Capital Management, Inc. being the largest institutional holder as of December 31, 2025. DNA Holdings Venture Inc., along with Scott Walker and Brock Pierce, beneficially owned approximately 19.99% of DNA X's outstanding shares as of December 15, 2025. Insiders have been involved in selling company stock in the past 24 months.

Expert AI

Show me the sentiment for DNA X, Inc.
What's the latest sentiment for DNA X, Inc.?

Price Chart

$3.16

5.73%
(1 month)

Top Shareholders

Potomac Capital Management, Inc.
3.22%
The Vanguard Group, Inc.
0.95%
BlackRock, Inc.
0.94%
Cannell Capital LLC
0.92%
UBS Group AG
0.58%
Geode Holdings Trust
0.29%
Philadelphia Trading, Inc.
0.15%
Ground Swell Capital LLC
0.06%

Trade Ideas for SONM

Today

Sentiment for SONM

News
Social

Buzz Talk for SONM

Today

Social Media

FAQ

What is the current stock price of DNA X, Inc.?

As of the latest update, DNA X, Inc.'s stock is trading at $3.16 per share.

What’s happening with DNA X, Inc. stock today?

Today, DNA X, Inc. stock is down by -5.73%, possibly due to news.

What is the market sentiment around DNA X, Inc. stock?

Current sentiment around DNA X, Inc. stock is positive, based on recent news, trading volume, and analyst opinions.

Is DNA X, Inc.'s stock price growing?

Over the past month, DNA X, Inc.'s stock price has decreased by -5.73%.

How can I buy DNA X, Inc. stock?

You can buy DNA X, Inc. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol SONM

Who are the major shareholders of DNA X, Inc. stock?

Major shareholders of DNA X, Inc. include institutions such as Potomac Capital Management, Inc. (3.22%), The Vanguard Group, Inc. (0.95%), BlackRock, Inc. (0.94%) ... , according to the latest filings.